Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	4.28	4.51	7.82	8.32	8.34
Cash & Cash Equivalents	4.28	4.51	7.82	8.32	8.34
Cash Growth	-4.99%	-42.36%	-5.96%	-0.22%	1.98%
Receivables	16.1	16.71	21.83	17.77	20.7
Inventory	24.72	26.44	27.59	22.26	22.06
Other Current Assets	3.94	3.47	4.34	3.36	2.47
Total Current Assets	49.04	51.12	61.58	51.7	53.57
Property, Plant & Equipment	8.75	9.18	10.31	11.72	13.24
Goodwill and Intangibles	73.1	77.27	85.07	91.74	95.79
Other Long-Term Assets	6.47	7.78	5.38	1.09	2.27
Total Long-Term Assets	88.33	94.24	100.76	104.55	111.3
Total Assets	137.37	145.36	162.34	156.25	164.87
Accounts Payable	5.55	6.45	4.91	5.97	5.34
Deferred Revenue	4.51	3.37	4.27	3.77	3.95
Current Debt	7.28	5.95	5.38	3.83	9.32
Other Current Liabilities	9.21	7.49	10.76	7.48	6.7
Total Current Liabilities	26.54	23.25	25.32	21.05	25.31
Long-Term Debt	35.5	48.3	51.58	53.77	55.14
Other Long-Term Liabilities	2.25	1.6	2.04	4.75	2.72
Total Long-Term Liabilities	37.75	49.89	53.63	58.52	57.86
Total Liabilities	64.29	73.14	78.94	79.57	83.18
Total Debt	42.77	54.24	56.96	57.6	64.47
Debt Growth	-21.14%	-4.77%	-1.11%	-10.65%	6.04%
Retained Earnings	-145.61	-142.19	-132.67	-132.39	-124.58
Comprehensive Income	-14.19	-15.05	-10.03	-13.07	-12.69
Shareholders' Equity	73.07	72.22	83.4	76.68	81.69
Net Cash / Debt	-38.49	-49.73	-49.14	-49.28	-56.13
Net Cash Per Share	-0.91	-1.20	-1.22	-1.28	-1.48
Working Capital	22.5	27.88	36.27	30.65	28.26
Book Value Per Share	1.72	1.74	2.07	1.98	2.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).